Carmat SA

CKMTF · NYSE

Price unavailable right now.

No price history for this range.

About CKMTF

Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 153 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. The company specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees: 153
Headquarters: Velizy-Villacoublay, Ile-De-France
Listed: Jul 7, 2010
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: carmatsa.com

Leadership

Carmat SA executives
Name	Title	Since	Age
Prof. Alain Carpentier	—	2019	—
Pierre Bastid	—	—	70
Stephane Piat	—	2016	51
Pascale D'Arbonneau	—	—	—
Raouia Bouyanzer	—	2021	—
Francesco Arecchi	—	—	—
Thierry Dupoux	—	—	—
Marc Grimme	—	2020	—
Prof. Christian Latremouille	—	—	—
Paolo Rampulla	—	—	—
Florent Battistella	—	—	60
Laurent Kirsch	—	—	—
Jean-Luc Lemercier	—	—	67
Michael Mack	—	—	75

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.